CANTON STRATEGIC HOLDINGS IN (CNTN) Fundamental Analysis & Valuation

NASDAQ:CNTN • US4327053090

Current stock price

3.38 USD
-0.12 (-3.57%)
At close:
3.48 USD
+0.1 (+2.96%)
Pre-Market:

This CNTN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CNTN Profitability Analysis

1.1 Basic Checks

  • In the past year CNTN has reported negative net income.
  • In the past year CNTN has reported a negative cash flow from operations.
  • CNTN had negative earnings in each of the past 5 years.
  • In the past 5 years CNTN always reported negative operating cash flow.
CNTN Yearly Net Income VS EBIT VS OCF VS FCFCNTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • CNTN has a worse Return On Assets (-134.03%) than 82.01% of its industry peers.
  • CNTN has a worse Return On Equity (-167.66%) than 66.34% of its industry peers.
Industry RankSector Rank
ROA -134.03%
ROE -167.66%
ROIC N/A
ROA(3y)-179.85%
ROA(5y)-342.76%
ROE(3y)-395.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNTN Yearly ROA, ROE, ROICCNTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

  • CNTN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNTN Yearly Profit, Operating, Gross MarginsCNTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

5

2. CNTN Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CNTN has been increased compared to 1 year ago.
  • CNTN has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for CNTN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CNTN Yearly Shares OutstandingCNTN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
CNTN Yearly Total Debt VS Total AssetsCNTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • CNTN has an Altman-Z score of 38.17. This indicates that CNTN is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of CNTN (38.17) is better than 94.58% of its industry peers.
  • CNTN has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • CNTN's Debt to Equity ratio of 0.03 is in line compared to the rest of the industry. CNTN outperforms 44.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 38.17
ROIC/WACCN/A
WACCN/A
CNTN Yearly LT Debt VS Equity VS FCFCNTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

  • A Current Ratio of 4.98 indicates that CNTN has no problem at all paying its short term obligations.
  • With a Current ratio value of 4.98, CNTN perfoms like the industry average, outperforming 55.51% of the companies in the same industry.
  • CNTN has a Quick Ratio of 4.98. This indicates that CNTN is financially healthy and has no problem in meeting its short term obligations.
  • CNTN has a Quick ratio (4.98) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.98
Quick Ratio 4.98
CNTN Yearly Current Assets VS Current LiabilitesCNTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

1

3. CNTN Growth Analysis

3.1 Past

  • CNTN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.73%, which is quite impressive.
EPS 1Y (TTM)77.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • CNTN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.09% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y5.23%
EPS Next 2Y41.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNTN Yearly EPS VS EstimatesCNTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -50 -100 -150 -200 -250

1

4. CNTN Valuation Analysis

4.1 Price/Earnings Ratio

  • CNTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CNTN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNTN Price Earnings VS Forward Price EarningsCNTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNTN Per share dataCNTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

  • CNTN's earnings are expected to grow with 41.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.09%
EPS Next 3YN/A

0

5. CNTN Dividend Analysis

5.1 Amount

  • No dividends for CNTN!.
Industry RankSector Rank
Dividend Yield 0%

CNTN Fundamentals: All Metrics, Ratios and Statistics

CANTON STRATEGIC HOLDINGS IN

NASDAQ:CNTN (3/19/2026, 8:00:01 PM)

Premarket: 3.48 +0.1 (+2.96%)

3.38

-0.12 (-3.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-25
Inst Owners22.24%
Inst Owner ChangeN/A
Ins Owners0.92%
Ins Owner ChangeN/A
Market Cap127.53M
Revenue(TTM)N/A
Net Income(TTM)-10.32M
Analysts82.86
Price TargetN/A
Short Float %9.68%
Short Ratio4.34
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 20.72
P/tB 20.72
EV/EBITDA N/A
EPS(TTM)-4.11
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0
BVpS0.16
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -134.03%
ROE -167.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-179.85%
ROA(5y)-342.76%
ROE(3y)-395.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.98
Quick Ratio 4.98
Altman-Z 38.17
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.28%
EPS Next Y5.23%
EPS Next 2Y41.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.67%
OCF growth 3YN/A
OCF growth 5YN/A

CANTON STRATEGIC HOLDINGS IN / CNTN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CANTON STRATEGIC HOLDINGS IN (CNTN) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CNTN.


What is the valuation status of CANTON STRATEGIC HOLDINGS IN (CNTN) stock?

ChartMill assigns a valuation rating of 1 / 10 to CANTON STRATEGIC HOLDINGS IN (CNTN). This can be considered as Overvalued.


Can you provide the profitability details for CANTON STRATEGIC HOLDINGS IN?

CANTON STRATEGIC HOLDINGS IN (CNTN) has a profitability rating of 0 / 10.


Can you provide the financial health for CNTN stock?

The financial health rating of CANTON STRATEGIC HOLDINGS IN (CNTN) is 5 / 10.